References
[1]Gorlick R, Groken E, Trippett T, Waltham M, Banerjee D, Bertino JR. Intrinsic and acquired resistance to methotrexate an acute leukamia[J]. N Engl J Med,1996, 335(14): 1041-1048.
[2]Wang Y, Zhao R, Goldman I. Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line[J]. Biochem Pharmacol, 2003, 65(7): 1163-1170.
[3]Liani E, Rothem L, Bunni M, Smith C, Jansen G, Assaraf YG. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines[J]. Int J Cancer, 2003, 103(5): 587-599.
[4]Stark M, Wichman C, Avivi I, Assaraf YG. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia[J]. Blood, 2009, 113(18): 4363-4369.
[5]孙利,沈佐君,何晓东. 氨甲蝶呤对映体耐药A549细胞株中叶酰聚谷氨酸合成酶mRNA和蛋白表达[J]. 安徽医科大学学报,2011,46(6):549-522.
[6]Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T, et al. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis[J]. Br J Clin Pharmacol, 2011, 71(2): 237-243.
[7]Adjei AA, Mandrekar SJ, Dy GK, Molina JR, Adjei AA, Gandara DR, et al. Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced nonsmallcell lung cancer: NCCTG and SWOG study N0426[J]. J Clin Oncol, 2010, 28(4): 614-619.
[8]杨天楹.急性白血病[M]//张之南. 血液病诊断及疗效标准.第2版.北京: 科学出版社,1998:168-214.
[9]McGuire JJ, Russell CA, Balinska M. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive andresistant human cell lines[J]. J Bio Chem, 2000, 275(17):13012-13016.
[10]Leclerc GJ, York TA, HsiehKinser T, Barredo JC. Molecular basis for decreased folypoly-gamma-glutamate synthetase expression in a methotrexate resistant CCRF-CEM mutatant cell line[J]. Leu Res, 2007, 31(3): 293-299.
[11]Figueiredo JC, Levine AJ, Lee WH, Lonti DV, Poynter JN, Campbell PT, et al. Genes involved with folate uptake and distribution and their association with colorectal cancer risk[J]. Cancer Causes Control, 2010, 21(4): 597-608.
[12]Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JN, et al. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms[J]. Br J Dermatol, 2009, 160(2): 438-441.